tiprankstipranks
Xencor Inc (CH:XE9)
:XE9
Switzerland Market

Xencor (XE9) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

XE9 Analyst Ratings

Strong Buy
11Ratings
Strong Buy
9 Buy
2 Hold
0 Sell
Based on 11 analysts giving stock ratings to
Xencor
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

XE9 Stock 12 Month Forecast

Average Price Target

Based on 11 Wall Street analysts offering 12 month price targets for Xencor in the last 3 months. The average price target is CHF20.32 with a high forecast of CHF30.74 and a low forecast of CHF11.32. The average price target represents a change from the last price of .
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
Highest Price TargetCHF30.74Average Price TargetCHF20.32Lowest Price TargetCHF11.32
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
William Blair Analyst forecast on CH:XE9
William Blair
William Blair
Buy
Reiterated
08/03/26
Analysts Offer Insights on Healthcare Companies: Xencor (NASDAQ: XNCR) and Twist Bioscience (NASDAQ: TWST)
Wedbush Analyst forecast on CH:XE9
Unknown Analyst
Wedbush
Not Ranked
Wedbush
CHF21.03
Buy
Reiterated
07/30/26
Xencor (XNCR) Receives a Buy from Wedbush
Barclays Analyst forecast on CH:XE9
Barclays
Barclays
CHF21.84
Buy
Reiterated
07/30/26
Barclays Remains a Buy on Xencor (XNCR)
Truist Financial Analyst forecast on CH:XE9
Truist Financial
Truist Financial
Buy
Reiterated
07/30/26
Analysts Offer Insights on Healthcare Companies: Biogen (NASDAQ: BIIB) and Xencor (NASDAQ: XNCR)
Bank of America Securities Analyst forecast on CH:XE9
Bank of America Securities
Bank of America Securities
CHF13.75
Hold
Reiterated
05/13/26
Bank of America Securities Sticks to Their Hold Rating for Xencor (XNCR)
TD Cowen
Buy
Reiterated
05/11/26
Analysts Conflicted on These Healthcare Names: Ginkgo Bioworks Holdings (NYSE: DNA), Xencor (NASDAQ: XNCR) and Alto Neuroscience, Inc. (NYSE: ANRO)
J.P. Morgan Analyst forecast on CH:XE9
J.P. Morgan
J.P. Morgan
CHF10.51CHF11.32
Hold
Assigned
05/11/26
Xencor price target raised to $14 from $13 at JPMorganXencor price target raised to $14 from $13 at JPMorgan
Piper Sandler Analyst forecast on CH:XE9
Piper Sandler
Piper Sandler
CHF26.69
Buy
Reiterated
05/08/26
Piper Sandler Reaffirms Their Buy Rating on Xencor (XNCR)
Wells Fargo Analyst forecast on CH:XE9
Unknown Analyst
Wells Fargo
Not Ranked
Wells Fargo
CHF21.84
Buy
Reiterated
05/07/26
Xencor (XNCR) Receives a Buy from Wells Fargo
Canaccord Genuity Analyst forecast on CH:XE9
Canaccord Genuity
Canaccord Genuity
CHF30.74
Buy
Reiterated
05/06/26
Analysts Offer Insights on Healthcare Companies: Xencor (NASDAQ: XNCR), Oscar Health (NYSE: OSCR) and REPRO-MED Systems (NASDAQ: KRMD)
RBC Capital Analyst forecast on CH:XE9
RBC Capital
RBC Capital
CHF15.37
Buy
Reiterated
05/05/26
Analysts' Top Healthcare Picks: Xencor (XNCR), Rhythm Pharmaceuticals (RYTM)
Cantor Fitzgerald Analyst forecast on CH:XE9
Cantor Fitzgerald
Cantor Fitzgerald
CHF34.78
Buy
Reiterated
02/25/26
Analysts Offer Insights on Healthcare Companies: Agilent (NYSE: A), Xencor (NASDAQ: XNCR) and Pennant Group (NASDAQ: PNTG)
Roth MKM Analyst forecast on CH:XE9
Unknown Analyst
Roth MKM
Not Ranked
Roth MKM
CHF4.85
Sell
Initiated
09/17/25
Xencor (XNCR) Receives a Sell from Roth MKM
Raymond James Analyst forecast on CH:XE9
Raymond James
Raymond James
CHF32.35
Buy
Reiterated
08/07/25
Leerink Partners Analyst forecast on CH:XE9
Leerink Partners
Leerink Partners
CHF21.84
Buy
Reiterated
08/07/25
Xencor (XNCR) Receives a Buy from Leerink Partners
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
William Blair Analyst forecast on CH:XE9
William Blair
William Blair
Buy
Reiterated
08/03/26
Analysts Offer Insights on Healthcare Companies: Xencor (NASDAQ: XNCR) and Twist Bioscience (NASDAQ: TWST)
Wedbush Analyst forecast on CH:XE9
Unknown Analyst
Wedbush
Not Ranked
Wedbush
CHF21.03
Buy
Reiterated
07/30/26
Xencor (XNCR) Receives a Buy from Wedbush
Barclays Analyst forecast on CH:XE9
Barclays
Barclays
CHF21.84
Buy
Reiterated
07/30/26
Barclays Remains a Buy on Xencor (XNCR)
Truist Financial Analyst forecast on CH:XE9
Truist Financial
Truist Financial
Buy
Reiterated
07/30/26
Analysts Offer Insights on Healthcare Companies: Biogen (NASDAQ: BIIB) and Xencor (NASDAQ: XNCR)
Bank of America Securities Analyst forecast on CH:XE9
Bank of America Securities
Bank of America Securities
CHF13.75
Hold
Reiterated
05/13/26
Bank of America Securities Sticks to Their Hold Rating for Xencor (XNCR)
TD Cowen
Buy
Reiterated
05/11/26
Analysts Conflicted on These Healthcare Names: Ginkgo Bioworks Holdings (NYSE: DNA), Xencor (NASDAQ: XNCR) and Alto Neuroscience, Inc. (NYSE: ANRO)
J.P. Morgan Analyst forecast on CH:XE9
J.P. Morgan
J.P. Morgan
CHF10.51CHF11.32
Hold
Assigned
05/11/26
Xencor price target raised to $14 from $13 at JPMorganXencor price target raised to $14 from $13 at JPMorgan
Piper Sandler Analyst forecast on CH:XE9
Piper Sandler
Piper Sandler
CHF26.69
Buy
Reiterated
05/08/26
Piper Sandler Reaffirms Their Buy Rating on Xencor (XNCR)
Wells Fargo Analyst forecast on CH:XE9
Unknown Analyst
Wells Fargo
Not Ranked
Wells Fargo
CHF21.84
Buy
Reiterated
05/07/26
Xencor (XNCR) Receives a Buy from Wells Fargo
Canaccord Genuity Analyst forecast on CH:XE9
Canaccord Genuity
Canaccord Genuity
CHF30.74
Buy
Reiterated
05/06/26
Analysts Offer Insights on Healthcare Companies: Xencor (NASDAQ: XNCR), Oscar Health (NYSE: OSCR) and REPRO-MED Systems (NASDAQ: KRMD)
RBC Capital Analyst forecast on CH:XE9
RBC Capital
RBC Capital
CHF15.37
Buy
Reiterated
05/05/26
Analysts' Top Healthcare Picks: Xencor (XNCR), Rhythm Pharmaceuticals (RYTM)
Cantor Fitzgerald Analyst forecast on CH:XE9
Cantor Fitzgerald
Cantor Fitzgerald
CHF34.78
Buy
Reiterated
02/25/26
Analysts Offer Insights on Healthcare Companies: Agilent (NYSE: A), Xencor (NASDAQ: XNCR) and Pennant Group (NASDAQ: PNTG)
Roth MKM Analyst forecast on CH:XE9
Unknown Analyst
Roth MKM
Not Ranked
Roth MKM
CHF4.85
Sell
Initiated
09/17/25
Xencor (XNCR) Receives a Sell from Roth MKM
Raymond James Analyst forecast on CH:XE9
Raymond James
Raymond James
CHF32.35
Buy
Reiterated
08/07/25
Leerink Partners Analyst forecast on CH:XE9
Leerink Partners
Leerink Partners
CHF21.84
Buy
Reiterated
08/07/25
Xencor (XNCR) Receives a Buy from Leerink Partners
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
MLYSMineralys Therapeutics, Inc.
ZURAZura Bio
TNYATenaya Therapeutics
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Xencor

3 Months
Gregory RenzaTruist Financial
Success Rate
9/19 ratings generated profit
47%
Average Return
-2.61%
Copying Gregory Renza's trades and holding each position for 3 Months would result in 47.37% of your transactions generating a profit, with an average return of -2.61% per trade.
1 Year
Edward TenthoffPiper Sandler
Success Rate
6/12 ratings generated profit
50%
Average Return
+18.02%
Copying Edward Tenthoff's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +18.02% per trade.
2 Years
Edward TenthoffPiper Sandler
Success Rate
7/12 ratings generated profit
58%
Average Return
+36.61%
Copying Edward Tenthoff's trades and holding each position for 2 Years would result in 58.33% of your transactions generating a profit, with an average return of +36.61% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

XE9 Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
9
9
7
8
2
Buy
5
5
3
7
5
Hold
2
4
3
3
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
16
18
13
18
7
In the current month, XE9 has received 7 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. XE9 average Analyst price target in the past 3 months is 20.32.
Each month's total comprises the sum of three months' worth of ratings.

XE9 Financial Forecast

XE9 Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.

XE9 Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

XE9 Stock Forecast FAQ

What is CH:XE9’s average 12-month price target, according to analysts?
Based on analyst ratings, Xencor Inc’s 12-month average price target is 20.32.
    What is CH:XE9’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:XE9, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Xencor Inc a Buy, Sell or Hold?
        Xencor Inc has a consensus rating of Strong Buy, which is based on 9 buy ratings, 2 hold ratings and 0 sell ratings.
          What is Xencor Inc’s share price target?
          The average share price target for Xencor Inc is 20.32. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is CHF30.74 ,and the lowest forecast is CHF11.32. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Xencor Inc?
            Xencor Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.
              How can I buy shares of Xencor Inc?
              To buy shares of CH:XE9, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.